Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Prytz

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Hepato-Gastroenterology|May 6, 1999
Spontaneous course of symptoms in primary sclerosing cholangitis: relationships with biochemical and histological featuresR Olsson, U Broomé, A Danielsson, et al.
Journal of Clinical Pathology|October 1, 1995
Sampling variability of percutaneous liver biopsy in primary sclerosing cholangitisR Olsson, I Hägerstrand, U Broomé, et al.
Gastroenterology|April 1, 1995
Colchicine treatment of primary sclerosing cholangitisR Olsson, U Broomé, A Danielsson, et al.
Gut|April 1, 1996
Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitisU Broomé, R Olsson, L Lööf, et al.
Tissue Antigens|July 30, 2002
HLA class II markers and clinical heterogeneity in Swedish patients with primary biliary cirrhosisR Wassmuth, F Depner, A Danielsson, et al.
Scandinavian Journal of Gastroenterology|February 1, 1997
Ursodeoxycholic acid treatment in patients with primary biliary cirrhosis. A Swedish multicentre, double-blind, randomized controlled studyL S Eriksson, R Olsson, H Glauman, et al.
Hepatology (Baltimore, Md.)|July 1, 1994
Cancer risk in primary biliary cirrhosis: a population-based study from SwedenL Lööf, H O Adami, P Sparén, et al.
Journal of Internal Medicine|August 19, 2007
Acute liver failure in Sweden: etiology and outcomeG Wei, A Bergquist, U Broomé, et al.
Alimentary Pharmacology & Therapeutics|January 7, 2012
High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasiaL Lindström, K M Boberg, O Wikman, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Hepato-Gastroenterology|May 6, 1999
Spontaneous course of symptoms in primary sclerosing cholangitis: relationships with biochemical and histological featuresR Olsson, U Broomé, A Danielsson, et al.
Journal of Clinical Pathology|October 1, 1995
Sampling variability of percutaneous liver biopsy in primary sclerosing cholangitisR Olsson, I Hägerstrand, U Broomé, et al.
Gastroenterology|April 1, 1995
Colchicine treatment of primary sclerosing cholangitisR Olsson, U Broomé, A Danielsson, et al.
Gut|April 1, 1996
Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitisU Broomé, R Olsson, L Lööf, et al.
Tissue Antigens|July 30, 2002
HLA class II markers and clinical heterogeneity in Swedish patients with primary biliary cirrhosisR Wassmuth, F Depner, A Danielsson, et al.
Scandinavian Journal of Gastroenterology|February 1, 1997
Ursodeoxycholic acid treatment in patients with primary biliary cirrhosis. A Swedish multicentre, double-blind, randomized controlled studyL S Eriksson, R Olsson, H Glauman, et al.
Hepatology (Baltimore, Md.)|July 1, 1994
Cancer risk in primary biliary cirrhosis: a population-based study from SwedenL Lööf, H O Adami, P Sparén, et al.
Journal of Internal Medicine|August 19, 2007
Acute liver failure in Sweden: etiology and outcomeG Wei, A Bergquist, U Broomé, et al.
Alimentary Pharmacology & Therapeutics|January 7, 2012
High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasiaL Lindström, K M Boberg, O Wikman, et al.
Pageof 5